37 results on '"Yajima, Hidetaka"'
Search Results
2. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment
3. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases
4. Risk of malignancies in IgG4-related disease
5. IgG4-related orbital tumour with eye enucleation—infra-orbital nerve enlargement
6. Necessity of early intervention for IgG4-related disease—delayed treatment induces fibrosis progression
7. Adult-onset Still’s disease in pregnancy
8. Relapse patterns in IgG4-related disease
9. Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
10. Efficacy of abatacept for IgG4-related disease over 8 months
11. Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission
12. Loss of interleukin-21 leads to atrophic germinal centers in multicentric Castleman’s disease
13. Tofacitinib can decrease anti-DNA antibody titers in inactive systemic lupus erythematosus complicated by rheumatoid arthritis
14. Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry
15. Seasonal allergies and serial changes of serum levels of IgG4 in cases treated with maintenance therapy for IgG4-related disease
16. CCAAT/enhancer binding protein α (C/EBPα)+M2 macrophages contribute to fibrosis in IgG4-related disease?
17. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: Results from the SMART database
18. The role of cytotoxic T cells in IgG4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease
19. Human herpesvirus 6 encephalitis in a patient with glucocorticoid therapy for inflammatory abdominal aortic aneurysm
20. Evaluation and Clinical Validity of a New Questionnaire for Mikulicz's Disease
21. Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease
22. Tophaceous Gout in the Cervical Spine
23. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases
24. Risk of malignancies in IgG4-related disease
25. Adult-onset Still’s disease in pregnancy
26. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: Results from the SMART database.
27. Efficacy of abatacept for IgG4-related disease over 8 months.
28. CCAAT/enhancer binding protein α (C/EBPα)+ M2 macrophages contribute to fibrosis in IgG4-related disease?
29. Tofacitinib can decrease anti-DNA antibody titers in inactive systemic lupus erythematosus complicated by rheumatoid arthritis.
30. Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission.
31. Seasonal allergies and serial changes of serum levels of IgG4 in cases treated with maintenance therapy for IgG4-related disease.
32. Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry.
33. CCAAT/enhancer binding protein α (C/EBPα)(+) M2 macrophages contribute to fibrosis in IgG4-related disease?
34. [Human herpesvirus 6 encephalitis in a patient with glucocorticoid therapy for inflammatory abdominal aortic aneurysm].
35. [A case of esophageal endocrine cell carcinoma with multiple liver metastases that had a complete response to multidisciplinary therapy].
36. [Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease].
37. Saturated and monounsaturated fatty acids increase interleukin-10 production in rat hepatocytes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.